| Date Filed | Type | Description |
| 01/11/2023 |
4
| Cole Hugh M (COO) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 7,452 shares
@ $1.1, valued at
$8.2k
Sold 9,182 shares
@ $1.12, valued at
$10.3k
|
|
| 08/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2022 |
4/A
| Cole Hugh M (Chief Business Officer) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Granted 85,000 options to buy
@ $7.56, valued at
$642.6k
|
|
| 02/03/2022 |
4
| Cole Hugh M (Chief Business Officer) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Granted 42,500 shares
@ $0
Granted 85,000 options to buy
@ $7.56, valued at
$642.6k
|
|
| 01/11/2022 |
4
| Cole Hugh M (Chief Business Officer) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 3,468 shares
@ $7.3, valued at
$25.3k
Sold 6,205 shares
@ $6.65, valued at
$41.3k
|
|
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2021 |
4
| Cole Hugh M (Chief Business Officer) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 18,000 shares
@ $11.95, valued at
$215.1k
Exercised 5,000 options to buy
@ $4.4, valued at
$22k
Exercised 5,000 options to buy
@ $6.55, valued at
$32.8k
|
|
| 01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2020 |
4
| Cole Hugh M (Chief Business Officer) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 984 shares
@ $4.64, valued at
$4.6k
Sold 454 shares
@ $4.86, valued at
$2.2k
Sold 744 shares
@ $4.71, valued at
$3.5k
|
|
| 06/12/2020 |
4
| Cole Hugh M (Director) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 7,500 options to buy
@ $6.17, valued at
$46.3k
|
|
| 02/04/2020 |
4
| Cole Hugh M (Chief Business Officer) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Granted 30,000 shares
@ $0
Granted 60,000 options to buy
@ $6.55, valued at
$393k
|
|
| 01/10/2020 |
4
| Cole Hugh M (Chief Business Officer) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 2,624 shares
@ $7.78, valued at
$20.4k
|
|
| 08/16/2019 |
4
| Cole Hugh M (Chief Business Officer) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 670 shares
@ $4.1, valued at
$2.7k
Sold 648 shares
@ $4, valued at
$2.6k
Sold 1,018 shares
@ $3.92, valued at
$4k
|
|
| 07/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/30/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2018 |
4
| Cole Hugh M (Chief Business Officer) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Granted 14,400 shares
@ $0 |
|
| 06/18/2018 |
4
| Cole Hugh M (Chief Business Officer) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Bought 1,900 shares
@ $7.84, valued at
$14.9k
|
|
| 02/05/2018 |
4
| Cole Hugh M (Chief Business Officer) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Granted 70,500 options to buy
@ $23.98, valued at
$1.7M
|
|
| 12/21/2017 |
3
| Cole Hugh M (Chief Business Officer) has filed a Form 3 on Jounce Therapeutics, Inc. |
| 02/16/2017 |
4
| Cole Hugh M (SVP, Chief Business Officer) has filed a Form 4 on ARIAD PHARMACEUTICALS INC|
Txns:
| Disposed/sold 42,834 shares
@ $0
Disposed/sold 100,000 options to buy
@ $6.4, valued at
$640k
Disposed/sold 78,000 options to buy
@ $6.51, valued at
$507.8k
Disposed/sold 64,733 restricted stock units
@ $0
Disposed/sold 9,788 restricted stock units
@ $0 |
|
| 02/07/2017 |
4
| Cole Hugh M (SVP, Chief Business Officer) has filed a Form 4 on ARIAD PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 6,249 shares
@ $8.69, valued at
$54.3k
Exercised 6,667 restricted stock units
@ $0
Exercised 12,500 restricted stock units
@ $0
Granted 9,788 restricted stock units
@ $0 |
|
| 06/29/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/02/2016 |
4
| Cole Hugh M (SVP, Chief Business Officer) has filed a Form 4 on ARIAD PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 5,634 shares
@ $7.18, valued at
$40.5k
Exercised 17,334 restricted stock units
@ $0 |
|
| 03/18/2016 |
4
| Cole Hugh M (SVP, Chief Business Officer) has filed a Form 4 on ARIAD PHARMACEUTICALS INC|
Txns:
| Exercised 7,500 shares
@ $6.21, valued at
$46.6k
Paid exercise price by delivering 2,438 shares
@ $6.21, valued at
$15.1k
Granted 15,000 rights
@ $0
Exercised 7,500 rights
@ $0 |
|
| 03/09/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |